Eric A. Secemsky, MD, MSc, RPVI, FSCAI, is the Director of Vascular Intervention in the CardioVascular Institute at Beth Israel Deaconess Medical Center, Section Head of Interventional Cardiology and Vascular Research at the Smith Center for Outcomes Research in Cardiology, and an Assistant Professor of Medicine at Harvard Medical School. Clinically, Dr. Secemsky splits his time attending in the cardiac catheterization lab and the inpatient and outpatient vascular medicine services. Dr. Secemsky is the primary vascular interventionalist within the BIDMC catheterization lab, where he does complex venous and arterial procedures, with a focus on peripheral artery disease. Dr. Secemsky's research focuses on the comparative effectiveness of coronary and vascular therapies with an emphasis on the use of novel statistical methods. He also examines outcomes related to cardiovascular disorders and the use of risk prediction models to guide treatment decisions. He has authored over 180 peer-reviewed publications and lectured nationally and internationally on his research. His research is funded by the National Institute for Health (NIH), Food and Drug Administration (FDA), Harvard Medical School, philanthropy, and extramural grants. He is an Associate Editor of Vascular Medicine and on the Editorial Board of Circulation: Cardiovascular Intervention and JSCAI. He also chairs the research committee of the PERT Consortium and is on the board of directors of the VIVA Foundation and the board of trustees of the Society for Vascular Medicine.

In 2023, Dr. Secemsky was the recipient of the SCAI-Cardiovascular System, Inc. Early Career Research Grant for his project, "Trends in Peripheral Vascular Interventions Through Pandemic and Controversy: An Analysis of the Changes in Modality, Setting, and Disparities in Treatment from 2016 to 2023"